PICHINI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 4.761
AS - Asia 2.216
EU - Europa 1.960
SA - Sud America 366
AF - Africa 153
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.469
Nazione #
US - Stati Uniti d'America 4.663
SG - Singapore 852
IT - Italia 496
RU - Federazione Russa 379
VN - Vietnam 375
CN - Cina 369
BR - Brasile 284
HK - Hong Kong 266
FR - Francia 195
DE - Germania 155
IE - Irlanda 154
SE - Svezia 130
GB - Regno Unito 115
UA - Ucraina 109
IN - India 88
CI - Costa d'Avorio 69
BD - Bangladesh 66
MX - Messico 49
FI - Finlandia 48
NL - Olanda 46
CA - Canada 33
JP - Giappone 30
ZA - Sudafrica 28
IQ - Iraq 27
PL - Polonia 27
TR - Turchia 27
BE - Belgio 24
AR - Argentina 23
AT - Austria 20
EC - Ecuador 17
ES - Italia 17
MA - Marocco 15
PK - Pakistan 15
ID - Indonesia 13
CO - Colombia 12
PH - Filippine 12
TH - Thailandia 10
VE - Venezuela 10
CL - Cile 9
AU - Australia 8
EG - Egitto 8
KR - Corea 8
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
DZ - Algeria 6
IR - Iran 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
IL - Israele 5
KE - Kenya 5
LT - Lituania 5
MY - Malesia 5
NP - Nepal 5
ET - Etiopia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
MT - Malta 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
BO - Bolivia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
CD - Congo 1
CM - Camerun 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
Totale 9.461
Città #
Ashburn 848
Singapore 558
Dallas 453
Chandler 328
San Jose 303
Hong Kong 261
Des Moines 237
Fairfield 226
Jacksonville 176
Dublin 154
Beijing 130
Seattle 114
Boardman 110
Ho Chi Minh City 109
Houston 108
Wilmington 106
Hanoi 99
New York 99
Woodbridge 96
Los Angeles 83
Cambridge 82
Lauterbourg 78
The Dalles 75
Moscow 70
Abidjan 69
Rome 63
Lawrence 58
Princeton 58
Munich 54
Council Bluffs 51
Milan 49
San Mateo 48
Ann Arbor 43
São Paulo 41
Turin 36
Buffalo 35
London 34
Ancona 32
Chicago 32
Helsinki 32
Mexico City 29
Orem 26
Hefei 24
Santa Clara 24
Denver 23
Warsaw 22
Da Nang 21
Pune 21
San Diego 21
Tokyo 21
Frankfurt am Main 20
Haiphong 20
Brooklyn 18
Brussels 17
Phoenix 17
Baghdad 16
Toronto 15
Turku 15
Washington 14
Chennai 13
Miano 13
Johannesburg 12
Shanghai 12
Atlanta 11
Centro 11
Manchester 11
San Francisco 11
Vienna 11
Boston 10
Falls Church 10
Poplar 10
Amsterdam 9
Boydton 9
Kilburn 9
Mohali 9
Stockholm 9
Cape Town 8
Columbus 8
Guarulhos 8
Montreal 8
Quito 8
Guangzhou 7
Izmir 7
Jinan 7
Messina 7
Norwalk 7
Querétaro 7
Salt Lake City 7
Tukwila 7
Verona 7
Wuhan 7
Ahmedabad 6
Ankara 6
Elk Grove Village 6
Nuremberg 6
Rio de Janeiro 6
Tashkent 6
Belo Horizonte 5
Brasília 5
Charlotte 5
Totale 6.363
Nome #
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 276
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy 240
Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol 229
Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study 186
New challenges in clinical and forensic toxicology 172
Analysis of perfluoroalkyl substances (PFAS) in conventional and unconventional matrices: Clinical outcomes 163
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 163
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 163
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 155
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 154
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 153
Monitoring Prenatal Exposure to Buprenorphine and Methadone 150
Toxicology and analysis of psychoactive tryptamines 145
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis" 142
Analytical procedures and blood threshold values to ascertain driving in a stae of psycho-physical impairment from drugs abuse|Procedure analitiche e valori decisionali ematici per accertare la guida in stato di alterazione psicofisica da sostanze d'abuso 132
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 132
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 131
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling 131
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 131
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 128
Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans 127
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 127
Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis 126
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 126
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 126
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 122
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 121
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry 121
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 121
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update 120
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone 119
Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease 118
European drug users at risk from illicit fentanyls mix 118
Pharmacology and legal status of cannabidiol 117
Pharmacological effects of methylone and MDMA in humans 117
Cannabidiol adverse effects and toxicity 116
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 116
Correspondence 115
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 113
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 110
Measurement uncertainty in forensic toxicology 110
Analytical advances in clinical and forensic toxicology. Second part 109
Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid 109
Evaluation of Short-Term Stability of Different Nitazenes Psychoactive Opioids in Dried Blood Spots by Liquid Chromatography-High-Resolution Mass Spectrometry 106
Comment on "direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes 105
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 102
Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis 102
Ultra-high-performance liquid chromatography tandem mass spectrometry assay for determination of endogenous ghb and ghb-glucuronide in nails 102
Advances and future developments in forensic toxicology: From standard practices to new psychoactive substances 101
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: A pilot study 100
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 99
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 98
Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties 97
Synthetic cathinones related fatalities: an update 97
Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages 96
Herbal highs: Review on Psychoactive Effects and Neuropharmacology 95
Pharmacotoxicology of non-fentanyl derived new synthetic opioids 95
Medicinal cannabis and synthetic cannabinoid use 95
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 94
A “special dose” of ethics in forensic toxicology 94
Cannabis: Neurological correlates in abuse and medical use 93
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs 91
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices 88
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 87
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 87
Metabolic pathways and potencies of new fentanyl analogs 86
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy 85
Erratum to Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 6, June 2023, 100944 83
The issue of psychotropic drug monitoring in sexual assault victims 81
Global prevalence of fetal alcohol spectrum disorder in Italy 81
Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry 77
The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report 75
Molecular Insights on New Psychoactive Substances (NPSs) 73
GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values 72
Molecular Insights of New Psychoactive Substances (NPS) 2.0 70
Editorial: Drug-drug interactions in pharmacology 67
GHB side effects: The need to clearly document drug dose and administration history 67
Target Analysis of NPS in Oral Fluid 67
Editorial: Analytical Advances in Clinical and Forensic Toxicology 64
Editorial: The challenge posed by new synthetic opioids: Pharmacology and toxicology 64
New psychoactive substances: A matter of time 64
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 61
Nails in Forensic Toxicology: an Update 59
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 58
Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations 58
The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances 57
GHB-facilitated sexual assaults: How to proper assess a single GHB exposure in hair 50
Totale 9.643
Categoria #
all - tutte 44.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/2022436 39 58 18 7 3 41 4 29 46 34 55 102
2022/20231.093 88 124 79 75 45 308 8 59 211 3 75 18
2023/2024590 79 12 80 53 83 115 26 20 8 17 14 83
2024/20251.693 117 118 88 71 86 124 141 92 347 115 154 240
2025/20264.741 351 480 336 343 537 256 820 394 361 417 182 264
Totale 9.643